Signaling network of Oncostatin M pathway
详细信息 查看全文
- 作者：Gourav Dey (1)
Aneesha Radhakrishnan (1) (2)
Nazia Syed (1) (2)
Joji Kurian Thomas (1) (3)
Arpitha Nadig (4)
Kotteazeth Srikumar (2)
Premendu Prakash Mathur (2) (7)
Akhilesh Pandey (5)
Sze-Kwan Lin (6)
Rajesh Raju (1)
T. S. Keshava Prasad (1) (3) - 刊名：Journal of Cell Communication and Signaling
- 出版年：2013
- 出版时间：June 2013
- 年：2013
- 卷：7
- 期：2
- 页码：103-108
- 全文大小：306KB
- 参考文献：1. Albasanz-Puig A, Murray J, Namekata M, Wijelath ES (2012) Opposing roles of STAT-1 and STAT-3 in regulating vascular endothelial growth factor expression in vascular smooth muscle cells. Biochem Biophys Res Commun 428(1):179鈥?84 ternal" href="http://dx.doi.org/10.1016/j.bbrc.2012.10.037">CrossRef
2. Arita K, South AP, Hans-Filho G, Sakuma TH, Lai-Cheong J, Clements S, Odashiro M, Odashiro DN, Hans-Neto G, Hans NR et al (2008) Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 82:73鈥?0 ternal" href="http://dx.doi.org/10.1016/j.ajhg.2007.09.002">CrossRef
3. Blanchard F, Wang Y, Kinzie E, Duplomb L, Godard A, Baumann H (2001) Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. J Biol Chem 276:47038鈥?7045 ternal" href="http://dx.doi.org/10.1074/jbc.M107971200">CrossRef
4. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O鈥橠onovan C, Phan I, Pilbout S, Schneider M (2003) The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res 31:365鈥?70 ternal" href="http://dx.doi.org/10.1093/nar/gkg095">CrossRef
5. Cao A, Wu M, Li H, Liu J (2011) Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells. J Lipid Res 52:518鈥?30 ternal" href="http://dx.doi.org/10.1194/jlr.M010603">CrossRef
6. Douglas AM, Goss GA, Sutherland RL, Hilton DJ, Berndt MC, Nicola NA, Begley CG (1997) Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene 14:661鈥?69 ternal" href="http://dx.doi.org/10.1038/sj.onc.1200882">CrossRef
7. Douglas AM, Grant SL, Goss GA, Clouston DR, Sutherland RL, Begley CG (1998) Oncostatin M induces the differentiation of breast cancer cells. Int J Cancer 75:64鈥?3 ternal" href="http://dx.doi.org/10.1002/(SICI)1097-0215(19980105)75:1<64::AID-IJC11>3.0.CO;2-D">CrossRef
8. Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R et al (1999) The DNA sequence of human chromosome 22. Nature 402:489鈥?95 ternal" href="http://dx.doi.org/10.1038/990031">CrossRef
9. Ensoli F, Fiorelli V, DeCristofaro M, Santini Muratori D, Novi A, Vannelli B, Thiele CJ, Luzi G, Aiuti F (1999) Inflammatory cytokines and HIV-1-associated neurodegeneration: oncostatin-M produced by mononuclear cells from HIV-1-infected individuals induces apoptosis of primary neurons. J Immunol 162:6268鈥?277
10. Fossey SL, Bear MD, Kisseberth WC, Pennell M, London CA (2011) Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines. BMC Cancer 11:125 ternal" href="http://dx.doi.org/10.1186/1471-2407-11-125">CrossRef
11. Goel R, Harsha HC, Pandey A, Prasad TSK (2012) Human protein reference database and human proteinpedia as resources for phosphoproteome analysis. Mol Biosyst 8:453鈥?63 ternal" href="http://dx.doi.org/10.1039/c1mb05340j">CrossRef
12. Goel R, Raju R, Maharudraiah J, Kumar GSS, Ghosh K, Kumar A, Lashmi PT et al (2011) A signaling network of thyroid-stimulating hormone. J Proteome Bioinforma 4:238鈥?41
13. Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 33:D514鈥揇517 ternal" href="http://dx.doi.org/10.1093/nar/gki033">CrossRef
14. Hasegawa M, Sato S, Ihn H, Takehara K (1999) Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis. Rheumatology (Oxford) 38:612鈥?17 ternal" href="http://dx.doi.org/10.1093/rheumatology/38.7.612">CrossRef
15. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1鈥?0 ternal" href="http://dx.doi.org/10.1042/BJ20030407">CrossRef
16. Hoffman RC, Moy FJ, Price V, Richardson J, Kaubisch D, Frieden EA, Krakover JD, Castner BJ, King J, March CJ, Powers R (1996) Resonance assignments for oncostatin M, a 24-kDa alpha-helical protein. J Biomol NMR 7:273鈥?82 ternal" href="http://dx.doi.org/10.1007/BF00200429">CrossRef
17. Kandasamy K, Keerthikumar S, Raju R, Prasad TSK, Ramachandra YL, Mohan S, Pandey A (2009) PathBuilder鈥搊pen source software for annotating and developing pathway resources. Bioinformatics 25:2860鈥?862 ternal" href="http://dx.doi.org/10.1093/bioinformatics/btp453">CrossRef
18. Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GS, Venugopal AK, Telikicherla D et al (2010) NetPath: a public resource of curated signal transduction pathways. Genome Biol 11:R3 ternal" href="http://dx.doi.org/10.1186/gb-2010-11-1-r3">CrossRef
19. Kok SH, Hou KL, Hong CY, Wang JS, Liang PC, Chang CC, Hsiao M, Yang H, Lai EH, Lin SK (2011) Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: a therapeutic benefit for arthritis. Arthritis Rheum 63:1010鈥?020 ternal" href="http://dx.doi.org/10.1002/art.27433">CrossRef
20. Li Q, Zhu J, Sun F, Liu L, Liu X, Yue Y (2011) Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3. Int J Mol Med 28:101鈥?08
21. Linsley PS, Kallestad J, Ochs V, Neubauer M (1990) Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M. Mol Cell Biol 10:1882鈥?890
22. Maglott D, Ostell J, Pruitt KD, Tatusova T (2005) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 33:D54鈥揇58 ternal" href="http://dx.doi.org/10.1093/nar/gki031">CrossRef
23. Migita K, Komori A, Torigoshi T, Maeda Y, Izumi Y, Jiuchi Y, Miyashita T, Nakamura M, Motokawa S, Ishibashi H (2011) CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes. Arthritis Res Ther 13:R72 ternal" href="http://dx.doi.org/10.1186/ar3333">CrossRef
24. Nanjappa V, Raju R, Muthusamy B, Sharma J, Thomas K, Nidhina PAH, Harsha HC, Pandey A, Anilkumar G, Prasad TSK (2011) A comprehensive curated reaction map of leptin signaling pathway. J Proteome Bioinforma 4:184鈥?89
25. Nicolaidou V, Wong MM, Redpath AN, Ersek A, Baban DF, Williams LM, Cope AP, Horwood NJ (2012) Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation. PLoS One 7:e39871 ternal" href="http://dx.doi.org/10.1371/journal.pone.0039871">CrossRef
26. O鈥橦ara KA, Kedda MA, Thompson PJ, Knight DA (2003) Oncostatin M: an interleukin-6-like cytokine relevant to airway remodelling and the pathogenesis of asthma. Clin exp allergy: j Br Soc Allergy Clin Immunol 33:1026鈥?032 ternal" href="http://dx.doi.org/10.1046/j.1365-2222.2003.01714.x">CrossRef
27. Prasad TSK, Kandasamy K, Pandey A (2009) Human protein reference database and human proteinpedia as discovery tools for systems biology. Methods Mol Biol 577:67鈥?9 ternal" href="http://dx.doi.org/10.1007/978-1-60761-232-2_6">CrossRef
28. Raju R, Balakrishnan L, Nanjappa V, Bhattacharjee M, Getnet D, Muthusamy B, Kurian Thomas J et al. (2011a) A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway. Database (Oxford) 2011: bar021
29. Raju R, Nanjappa V, Balakrishnan L, Radhakrishnan A, Thomas JK, Sharma J, Tian M, Palapetta SM, Subbannayya T et al. (2011b) NetSlim:high-confidence curated signaling maps. Database (Oxford) 2011:bar032
30. Ruprecht K, Kuhlmann T, Seif F, Hummel V, Kruse N, Bruck W, Rieckmann P (2001) Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions. J Neuropathol Exp Neurol 60:1087鈥?098
31. Sarkozi R, Hauser C, Noppert SJ, Kronbichler A, Pirklbauer M, Haller VM, Grillari J, Grillari-Voglauer R, Mayer G, Schramek H (2011) Oncostatin M is a novel inhibitor of TGF-beta1-induced matricellular protein expression. Am J Physiol Renal Physiol 301:F1014鈥揊1025 ternal" href="http://dx.doi.org/10.1152/ajprenal.00123.2011">CrossRef
32. Schaefer LK, Wang S, Schaefer TS (2000) Oncostatin M activates stat DNA binding and transcriptional activity in primary human fetal astrocytes: low- and high-passage cells have distinct patterns of stat activation. Cytokine 12:1647鈥?655 ternal" href="http://dx.doi.org/10.1006/cyto.2000.0774">CrossRef
33. Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797鈥?19 ternal" href="http://dx.doi.org/10.1146/annurev.immunol.15.1.797">CrossRef
34. Tanaka M, Miyajima A (2003) Oncostatin M, a multifunctional cytokine. Rev Physiol Biochem Pharmacol 149:39鈥?2 ternal" href="http://dx.doi.org/10.1007/s10254-003-0013-1">CrossRef
35. Thoma B, Bird TA, Friend DJ, Gearing DP, Dower SK (1994) Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem 269:6215鈥?222
36. Tu HJ, Lin TH, Chiu YC, Tang CH, Yang RS, Fu WM (2012) Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts. J Cell Physiol
37. Van Wagoner NJ, Choi C, Repovic P, Benveniste EN (2000) Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J Neurochem 75:563鈥?75 ternal" href="http://dx.doi.org/10.1046/j.1471-4159.2000.0750563.x">CrossRef
38. Weiss TW, Kvakan H, Kaun C, Zorn G, Speidl WS, Pfaffenberger S, Maurer G, Huber K, Wojta J (2005) The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart. J Mol Cell Cardiol 39:545鈥?51 ternal" href="http://dx.doi.org/10.1016/j.yjmcc.2005.03.015">CrossRef
39. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ (1986) Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci U S A 83:9739鈥?743 ternal" href="http://dx.doi.org/10.1073/pnas.83.24.9739">CrossRef
40. Zhang F, Li C, Halfter H, Liu J (2003) Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells. Oncogene 22:894鈥?05 ternal" href="http://dx.doi.org/10.1038/sj.onc.1206158">CrossRef - 作者单位：Gourav Dey (1)
Aneesha Radhakrishnan (1) (2)
Nazia Syed (1) (2)
Joji Kurian Thomas (1) (3)
Arpitha Nadig (4)
Kotteazeth Srikumar (2)
Premendu Prakash Mathur (2) (7)
Akhilesh Pandey (5)
Sze-Kwan Lin (6)
Rajesh Raju (1)
T. S. Keshava Prasad (1) (3)
1. Institute of Bioinformatics, International Tech Park, Whitefield, Bangalore, 560 066, India
2. Department of Biochemistry and Molecular Biology, School of Life Sciences, Pondicherry University, Puducherry, 605 014, India
3. School of Biotechnology, Amrita Vishwa Vidhyapeetam, Kollam, 690 525, India
4. Department of Bioinformatics, Kuvempu University, Karnataka, Shankaraghatta, 577 451, India
7. KIIT University, Bhubaneswar, 751 024, India
5. McKusick-Nathans Institute of Genetic Medicine and Departments of Biological Chemistry, Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA
6. School of Dentistry, College of Medicine, National Taiwan University, 1 Chang-Te Street, Taipei, 10016, Taiwan
文摘